Boehringer Ingelheim introduces new purification technology

Pharma |  News | 0 Comment | 08 Jan, 2020

When launched, Ingelvac CircoFLEX® was the first PCV2 vaccine that could be freshly mixed with an M hyo vaccine and is still considered one of the most revolutionary PCV2 vaccines ...Read more

aTyr Pharma, Kyorin to work on interstitial lung diseases

Pharma |  News | 0 Comment | 07 Jan, 2020

US based aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, has announced that it has enter...Read more

Yisheng inks oncology deal with Tavotek

Pharma |  News | 0 Comment | 07 Jan, 2020

China headquartered Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, a...Read more

Antengene Corporation appoints former Celgene China GM John Chin as CBO

Pharma |  News | 0 Comment | 07 Jan, 2020

Antengene Corporation has announced its appointment of Mr. John Chin, MBA, as Chief Business Officer (CBO). He will be responsible for the company's global business development and commerci...Read more

I-Mab Biopharma commences pivotal study of TJ202/MOR202 in China

Pharma |  News | 0 Comment | 06 Jan, 2020

I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States and focused on the discovery and development of novel or highly differ...Read more

Pulmatrix enters into agreement with J&J

Pharma |  News | 0 Comment | 03 Jan, 2020

US based Pulmatrix, Inc., a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary diseases, has announced that it has entered into a ...Read more

BeiGene completes acquisition deal with Amgen

Pharma |  News | 0 Comment | 03 Jan, 2020

BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer has ann...Read more

CF PharmTech to accelerate respiratory drugs development

Pharma |  News | 0 Comment | 02 Jan, 2020

China based CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million ...Read more

Urovant inks $300M loan agreement with Sumitomo Pharma

Pharma |  News | 0 Comment | 02 Jan, 2020

Urovant Sciences, a subsidiary of Sumitomo Dainippon Pharma has announced that it has entered into a $300 million term loan facility with Sumitomo Dainippon Pharma, a leading global Japanes...Read more

GSK completes divestment of travel vaccines to Bavarian Nordic

Pharma |  News | 0 Comment | 02 Jan, 2020

GlaxoSmithKline has announced the completion of the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick...Read more

Hana Pharm submits NDA for anesthetic agent

Pharma |  News | 0 Comment | 31 Dec, 2019

Germany headquartered pharmaceutical company PAION AG has announced that its South Korean remimazolam licensee Hana Pharm has informed PAION about the submission of a New Drug Application (...Read more

Daiichi Sankyo unveils drug for treating colorectal cancer

Pharma |  News | 0 Comment | 31 Dec, 2019

Daiichi Sankyo Company has announced that it has launched the antitumor agent bevacizumab BS for intravenous drip infusions 100 mg and 400 mg “Daiichi Sankyo” (generic name: bev...Read more

Oncologie Selected as Top 100 Innovative Pharmaceutical Company in China

Pharma |  News | 0 Comment | 30 Dec, 2019

Oncologie, a biopharmaceutical company with innovative oncology therapeutics supported by a biomarker platform to select patients, on 27 Dec 2019, announced that it has been selected as a T...Read more

FDA grants ODD to pancreatic cancer drug candidate by OBI Pharma

Pharma |  News | 0 Comment | 30 Dec, 2019

OBI Pharma, Inc., a Taiwan biopharma company has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for OBI-999 for the...Read more

Astellas strengthens immuno-oncology portfolio by acquiring Xyphos

Pharma |  News | 0 Comment | 27 Dec, 2019

Japan based Astellas Pharma Inc. and US headquartered Xyphos Biosciences, Inc. have announced that Astellas has acquired Xyphos. With the acquisition Astellas will gain Xyphos' novel a...Read more

Shanghai to host bioLIVE China 2020

Pharma |  News | 0 Comment | 27 Dec, 2019

To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry---bioLIVE China 2020, will b...Read more

Gilead, Eisai to co-promote drug in Japan for RA treatment

Pharma |  News | 0 Comment | 26 Dec, 2019

Gilead Sciences, Inc. and Eisai Co., Ltd. have announced that Gilead Sciences K.K. and Eisai have entered into an agreement for the distribution and co-promotion of filgotinib, an investiga...Read more

Mankind, Glenmark to co-market anti-diabetes drug in India

Pharma |  News | 0 Comment | 24 Dec, 2019

Mankind Pharmaceuticals Ltd. and Glenmark Pharmaceuticals Ltd. have inked a sub-licensing agreement to co-market sodium glucose co-transporter-2 (SGLT2) inhibitor, Remogliflo...Read more